# The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy

> **NCT07475065** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Universitas Sebelas Maret** · enrollment: 34 (estimated)

## Conditions studied

- Diabetic Polyneuropathy
- Peripheral Nervous System Diseases
- Peripheral Neuropathy
- Diabetes Mellitus

## Interventions

- **DRUG:** DLBS1033
- **DRUG:** Placebo Comparator: Placebo + Standard Therapy

## Key facts

- **NCT ID:** NCT07475065
- **Lead sponsor:** Universitas Sebelas Maret
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2026-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07475065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07475065, "The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT07475065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*